The MRC Clinical Trials Unit (CTU) is a centre of excellence for clinical trials, meta-analyses and epidemiological studies

We are committed to strengthening and expanding the evidence base for healthcare nationally and internationally.

The CTU also develops methodology to improve the design, conduct and analysis of clinical studies, and hosts one of the MRC’s eight regional Hubs for Trials Methodology Research.

The MRC CTU is a UKCRC registered trials unit.

click on the right Read more about the Unit 

Latest News

NEAT001 finds an alternative combination of drugs for first-line treatment of HIV

The results of the NEAT001/ANRS143 trial, published today in The Lancet, show that a new combination of antiretroviral drugs could be an alternative to the standard approach recommended in guidelines. This new combination may be helpful for people who have problems with the side effects of the current standard treatment.

Purple Right Arrow Read full report

MRC CTU at UCL calls on researchers, funders and doctors to do more multi-arm trials

Researchers from MRC CTU at UCL have called for a move away from traditional ‘two-arm' trials towards a ‘multi-arm’ approach that could speed up the process of getting effective new treatments to patients. This call comes in a commentary piece published in The Lancet on 25 July 2014.

Purple Right Arrow Read full report

Results of CHAPAS-3 trial on which drugs to use for children with HIV in Africa

The results of the CHAPAS-3 trial were presented by Victor Musiime at the 6th International Workshop on HIV Pediatrics in Melbourne on 19 July. CHAPAS-3 looked into the safety and effectiveness of three different drugs used as part of a combination to treat children with HIV in Africa. One of the main findings from the trial was that children respond very well to HIV treatment, regardless of which specific treatment they receive.

Purple Right Arrow Read full report

Other news

prarrow More news and press releases

Our Research Areas

Browser does not support script.